Sort   by:  
 Page size 
UnknownAssociation of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical Trial.
Not available
S-EPMC8267845 | biostudies-literature
UnknownPhase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors.
Not available
S-EPMC8261871 | biostudies-literature
UnknownOlutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndrome.
Not available
S-EPMC12552956 | biostudies-literature
UnknownPhase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.
Not available
S-EPMC3137402 | biostudies-literature
UnknownMolecular patterns identify distinct subclasses of myeloid neoplasia.
Not available
S-EPMC10229666 | biostudies-literature
UnknownLarge-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer.
Not available
S-EPMC11442451 | biostudies-literature
UnknownMosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial.
Not available
S-EPMC10803244 | biostudies-literature
UnknownPhase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
Not available
S-EPMC9872507 | biostudies-literature
UnknownAssociations of Allostatic Load with Level of and Change in Cognitive Function Among Middle-Aged and Older Hispanic/Latino Adults: The Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).
Not available
S-EPMC11343490 | biostudies-literature
UnknownHOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
Not available
S-EPMC8007823 | biostudies-literature
Sort   by:  
 Page size